Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Jun 15, 2026; 18(6): 117904
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117904
Published online Jun 15, 2026. doi: 10.4251/wjgo.v18.i6.117904
Gamma delta T-cell infusion plus chemotherapy induces long-term remission of gastric cancer after immunochemotherapy failure: A case report
Yi-Hua Wu, Li-Yuan Bai, Department of Internal Medicine, China Medical University Hospital, Taichung 404327, Taiwan
Yi-Hua Wu, Horng-Ren Yang, School of Medicine, China Medical University, Taichung 404327, Taiwan
Kai-Po Chang, Department of Pathology, China Medical University Hospital, Taichung 404327, Taiwan
Long-Bin Jeng, Cell Therapy Center, China Medical University Hospital, Taichung 404327, Taiwan
Author contributions: Bai LY, Wu YH, and Jeng LB designed the report; Wu YH collected the patient clinical data and drafted the manuscript; Chang KP performed and interpreted the pathological examinations; Yang HR and Jeng LB performed the surgical treatment; Bai LY and Jeng LB reviewed and revised the manuscript; all authors have read and approved the final manuscript.
AI contribution statement: The use of AI tools (such as Grammarly) is to enhance readability and optimize language expression within a certain scope. These AI tools do not participate in the case presentation, result interpretation, or the generation of any images included in the manuscript. The author is fully responsible for the content and integrity of the work. The scientific content of this manuscript, including cases, laboratory data analysis, and the interpretation of results and images, was entirely developed and written by the author.
Informed consent statement: Informed written consent was obtained from the patient for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Long-Bin Jeng, Chief Professor, Cell Therapy Center, China Medical University Hospital, No. 2 Yude Road, North District, Taichung 404327, Taiwan.
Received: January 16, 2026
Revised: February 13, 2026
Accepted: March 11, 2026
Published online: June 15, 2026
Processing time: 167 Days and 17.4 Hours
Revised: February 13, 2026
Accepted: March 11, 2026
Published online: June 15, 2026
Processing time: 167 Days and 17.4 Hours
Core Tip
Core Tip: Long-term survival after progression on immunochemotherapy is uncommon in metastatic gastric cancer. We report a patient with stage IV gastric adenocarcinoma who achieved radiologic and pathologic complete response after the addition of autologous gamma delta (γδ) T-cell infusions to ramucirumab and trifluridine/tipiracil. Because γδ T cells recognize stressed tumor cells independent of the major histocompatibility complex, they may retain antitumor activity even when immune checkpoint blockade fails. This case is hypothesis-generating and supports further investigation of γδ T-cell-based immunotherapy in gastric cancer.